GTI completes much anticipated maiden drilling at Jeffrey project

|

Published 25-JUN-2020 09:41 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

GTI Resources Ltd (ASX:GTR) has completed its maiden drill program on schedule at the Jeffrey Project which as shown on the map below is in the Henry Mountains region of Utah in the US.

The program successfully achieved the drilling and down-hole gamma logging of the targeted 12 diamond core drill holes to test the extent of shallow uranium and vanadium mineralisation across the southern portion of the Jeffrey project.

This has been a much-anticipated exploration program, highlighted by the seven-fold increase in the company’s share price over the last three months.

Consequently, given management’s upbeat commentary regarding this latest news there could be further share price momentum.

Given the shallow nature of the mineralised horizon, a total of 182 metres of core drilling was sufficient to gather a meaningful data set.

In addition to the 12 new drill holes, a further 6 historical drill holes were located near the newly drilled holes and subsequently logged with a downhole gamma probe.

This phase of exploration has quickly yielded data from 44 drill holes, including data from previous drilling, and this will be utilised to inform GTI’s understanding of the mineralisation and to guide the next phase of exploration.

Potential for larger drill program to establish Mineral Resource

The next exploration phase may entail a much larger drill program, targeting potential development of a JORC code compliant Mineral Resource, ultimately guiding future production studies.

The shallow nature of the mineralisation allows for relatively low-cost rapid exploration.

The eU3O8 downhole gamma probe assay data for the 12 new and 6 historical drill holes are being processed and are expected to be available for reporting within the next 10 days.

The drill core is being logged, cut and sampled for laboratory analysis with assay results expected by mid-August.

Completion of the maiden drill program satisfies a second of the three performance milestones attached to the performance rights issued.

The capital raising milestone was achieved with the recent exercise of 25,750,000 options.

With satisfaction of two of the three performance milestones now confirmed, the GTI’s board has deemed the performance rights to be vested.

GTI is moving to rapidly advance its projects in Utah given the potential to supply high-grade uranium ore to help fill existing local mill processing capacity.

Management is also actively looking for value accretive opportunities to expand its US project portfolio in this space.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X